Kraig Biocraft Laboratories, Inc. (KBLB)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Research and development | 63,888 | 23,876 | 24,968 | 49,414 |
| Professional fees | 43,625 | 63,035 | 40,922 | 104,198 |
| Officers salary | 186,197 | 184,730 | 152,609 | 234,788 |
| General and administrative | 344,035 | 308,851 | 205,298 | 1,097,738 |
| Total operating expenses | 637,745 | 580,492 | 423,797 | 1,486,138 |
| Loss from operations | -637,745 | -580,492 | -423,797 | -1,486,138 |
| Interest income | - | - | - | 20,296 |
| Other nonoperating expense | - | - | - | 130,889 |
| Impairment of right of use asset | - | - | - | 30,084 |
| Gain on asset impairment | - | - | 30,084 | - |
| Interest expense | 141,986 | 140,348 | 132,890 | - |
| Interest income | 1,140 | 3,319 | 14,983 | - |
| Gain on sale of gold | 62,469 | - | - | - |
| Net change in unrealized depreciation on investment in gold bullion | 10,011 | -117,488 | -78,420 | -20,626 |
| Impairment of right-of-use asset | - | - | - | - |
| Total other income/(expenses) | -88,388 | -19,541 | -9,403 | -120,051 |
| Net (loss) before provision for income taxes | -726,133 | -600,033 | -433,200 | -1,606,189 |
| Provision for income taxes | - | - | - | - |
| Net (loss) | -726,133 | -600,033 | -433,200 | -1,606,189 |
| Comprehensive income (loss), net of tax, attributable to parent | - | - | -433,200 | -1,606,189 |
| Net income (loss) per share - basic | - | - | - | - |
| Net income (loss) per share - diluted | - | - | - | - |
| Weighted average number of shares outstanding during the period - basic | 1,047,493,242 | 1,041,458,063 | 1,038,374,219 | 1,038,374,219 |
| Weighted average number of shares outstanding during the period - diluted | 1,047,493,242 | 1,041,458,063 | 1,038,374,219 | 1,038,374,219 |